Aripiprazole Oral Acceptability Trial

Completed · Phase 3

Conditions studied: Schizophrenia

In brief

The purpose of this trial is to study liquid aripiprazole in patients with stable schizophrenia.

Key facts

Study ID

NCT00101569

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

People needed

59

Starts

2004-03-01

Expected to finish

2005-03-01

Last updated by the study team

2013-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stable patients currently receiving aripiprazole or other antipsychotic medications.

Where it is running

• Local Institution — Anaheim, California, United States
• Local Institution — National City, California, United States
• Local Institution — North Miami Beach, Florida, United States
• Local Institution — Overland Park, Kansas, United States
• Local Institution — Staten Island, New York, United States
• Local Institution — Oklahoma City, Oklahoma, United States
• Local Institution — Falls Church, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.